Reuters Health Information (2005-08-15): FDA approves use of Merck hepatitis A vaccine in 1-year-olds
FDA approves use of Merck hepatitis A vaccine in 1-year-olds
Last Updated: 2005-08-15 16:42:46 -0400 (Reuters Health)
NEW YORK (Reuters) - Merck & Co. on Monday said
U.S. regulators have approved use of its already marketed hepatitis A
vaccine, Vaqta, for children as young as 12 months old, rather than the
previous approved use for patients at least 2 years of age.
There were an estimated 8,800 reported cases of hepatitis A in the United States during 2002, the drugmaker said.